Cite
HARVARD Citation
Creticos, C. et al. (n.d.). 537STaR: Single-Tablet Regimen Rilpivirine/Emtricitabine/Tenofovir DF has Similar Efficacy and is Well-Tolerated Compared to Efavirenz/Emtricitabine/Tenofovir DF in ART-Naïve Females at Week 96. Open forum infectious diseases. p. S21. [Online].